Source: Energia Foundation Incorporated
As the Arabian Peninsula works to lead cutting-edge sectors, once taboo treatments are beginning to be considered, discussed, and researched.
DUBAI, Arab Emirates, June 5, 2023 (Newswire.com) – The Energia Foundation is thrilled to announce a milestone in psychedelic therapeutics education in the Arab region, as part of the ‘Dialogues in Mental Health: Novel Treatments in Mood Disorders conference held in partnership with Tabula Rasa Ventures, Reem Neuroscience center, Abu Dhabi and The Valens Clinic Dubai. This academic event, set to take place on June 10th in Dubai, UAE, will explore the latest advances in mental health disorders including Neuromodulation, Esketamine, redirection of medication and marks the first-ever conference with dedicated programming exploring the global advancement in the field of psychedelic-assisted therapies.
Novel Treatments in Mood Disorders aims to catalyze a new era of education, research collaboration, and professional development in mental health and the treatment of mood disorders. With a growing global recognition of the therapeutic potential of psychedelic-assisted therapies, this conference will play a pivotal role in bringing this cutting-edge modality to the forefront of health systems in the region. A distinguished lineup of international experts, renowned researchers, clinicians, and thought leaders in the field of psychedelic-assisted therapies will be presenting their latest work, including: Rachel Yehuda, Director of the Mt. Sinai Center for Psychedelic Psychotherapy and Trauma Research, Jesse Gould, Founder of the Heroic Hearts Project, and Maria Velkova, Managing Partner of Tabula Rasa Ventures.
We are excited to pioneer education around the potential for psychedelic therapeutics in the MENA region,” said Marik Hazan, Executive Director at the Energia Foundation. “This conference will foster dialogue, collaboration, and education among professionals, researchers, and stakeholders, while promoting a medicalized, therapeutic, and evidence-based approach to psychedelic-assisted therapies.
Novel Treatments in Mood Disorders will provide a platform for attendees to explore a wide range of
topics related to psychedelic therapeutics, including the potential applications in mental health
treatments, substance abuse disorders, palliative care, and post-traumatic stress disorder (PTSD).
Through in-depth discussions and workshops, participants will gain a deeper understanding of the therapeutic mechanisms, best practices, and regulatory frameworks associated with psychedelicassisted treatments.
We started the Dialogues in Mental Health Series with Dr Samer Makhoul a year ago and are thrilled to see its growing impact amongst the mental health community in the GCC,” added Joseph ElKhoury, Founder of the Valens Clinic, Dubai. “Therapists in the region are staying updated on the latest scientific evidence and clinical trials, desperately looking for ways to help move the needle on patient outcomes in mental health. Practitioners are aware of the developments, particularly in the US, but are keen on in-person networking, training, education, and collaboration to sharpen their understanding of these innovative therapies. This conference is a keystep to bring the region up to speed with progress on the international scene with the ultimate aim to reduce the burden of mental health ailments in the region.
Novel Treatments in Mood Disorders welcomes professionals, researchers, therapists, policymakers, and individuals interested in the field of psychedelic-assisted therapies to join this landmark event. Request for invitation and further details about the conference can be found on the official conference website: energiafoundation.org/mena